Want to see TSE:ASTI full AI Analyst Report?
Aquarius Surgical Technologies (ASTI) Ratios
1 Followers
Aquarius Surgical Technologies Ratios
TSE:ASTI's free cash flow for Q4 2026 was C$-11.61K. For the 2026 fiscal year, TSE:ASTI's free cash flow was increased by C$0.00 and operating cash flow was C$-11.61K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 23 | Mar 22 | Jun 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.06 | 0.06 | 0.18 | 0.64 | 1.97 |
| Quick Ratio | 0.06 | 0.05 | 0.15 | 0.62 | 1.65 |
| Cash Ratio | 0.02 | 0.00 | 0.08 | 0.15 | 0.33 |
| Solvency Ratio | -0.08 | -0.15 | -0.16 | -0.50 | -0.63 |
| Operating Cash Flow Ratio | -0.06 | -0.22 | 0.03 | -0.45 | -2.94 |
| Short-Term Operating Cash Flow Coverage | -0.20 | -0.83 | 0.08 | -0.78 | 0.00 |
| Net Current Asset Value | C$ -8.22M | C$ -7.62M | C$ -4.26M | C$ -2.70M | C$ -1.71M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 3.63 | 3.32 | 5.16 | 3.09 | 1.22 |
| Debt-to-Equity Ratio | -1.08 | -1.12 | -0.91 | -1.22 | -2.94 |
| Debt-to-Capital Ratio | 13.35 | 9.28 | -10.40 | 5.51 | 1.52 |
| Long-Term Debt-to-Capital Ratio | -116.55 | 32.37 | -3.21 | -47.33 | 1.52 |
| Financial Leverage Ratio | -0.30 | -0.34 | -0.18 | -0.40 | -2.41 |
| Debt Service Coverage Ratio | -0.25 | -1.08 | -0.75 | -1.40 | -3.81 |
| Interest Coverage Ratio | -0.64 | -1.72 | -3.04 | -1.77 | -4.23 |
| Debt to Market Cap | 16.77 | 11.62 | 13.70 | 0.61 | 0.27 |
| Interest Debt Per Share | 0.27 | 0.25 | 0.15 | 0.14 | 0.11 |
| Net Debt to EBITDA | -28.53 | -7.76 | -6.55 | -2.08 | -1.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.61% | 51.87% | 40.21% | 37.12% | 39.45% |
| EBIT Margin | -281.59% | -945.11% | -257.76% | -252.11% | -137.12% |
| EBITDA Margin | -264.53% | -913.15% | -253.93% | -228.87% | -123.47% |
| Operating Profit Margin | -281.59% | -598.19% | -326.14% | -112.64% | -137.12% |
| Pretax Profit Margin | -706.03% | -1278.19% | -355.09% | -310.30% | -168.00% |
| Net Profit Margin | -712.75% | -1279.85% | -355.09% | -310.30% | -168.00% |
| Continuous Operations Profit Margin | -712.75% | -1279.85% | -355.09% | -310.30% | -168.00% |
| Net Income Per EBT | 100.95% | 100.13% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 250.73% | 213.68% | 108.88% | 275.48% | 122.52% |
| Return on Assets (ROA) | -34.06% | -59.88% | -106.37% | -191.35% | -97.09% |
| Return on Equity (ROE) | 10.14% | 20.22% | 18.80% | 75.60% | 233.71% |
| Return on Capital Employed (ROCE) | 471.11% | -260.26% | 79.67% | 1326.41% | -98.43% |
| Return on Invested Capital (ROIC) | -49.51% | -78.23% | 196.86% | -123.66% | -98.43% |
| Return on Tangible Assets | -34.06% | -59.88% | -106.37% | -191.35% | -97.09% |
| Earnings Yield | -157.42% | -211.46% | -291.13% | -37.59% | -21.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.79 | 1.91 | 2.67 | 1.28 | 2.49 |
| Payables Turnover | 0.04 | 0.04 | 0.75 | 0.88 | 1.80 |
| Inventory Turnover | 0.00 | 2.19 | 2.79 | 17.39 | 5.51 |
| Fixed Asset Turnover | 0.00 | 1.86 | 1.95 | 1.92 | 0.94 |
| Asset Turnover | 0.05 | 0.05 | 0.30 | 0.62 | 0.58 |
| Working Capital Turnover Ratio | -0.05 | -0.05 | -0.18 | -29.39 | 3.42 |
| Cash Conversion Cycle | -8160.28 | -10051.20 | -221.14 | -106.28 | 9.27 |
| Days of Sales Outstanding | 204.29 | 191.13 | 136.59 | 285.33 | 146.30 |
| Days of Inventory Outstanding | 0.00 | 166.99 | 130.96 | 20.99 | 66.24 |
| Days of Payables Outstanding | 8364.57 | 10409.32 | 488.69 | 412.60 | 203.28 |
| Operating Cycle | 204.29 | 358.12 | 267.55 | 306.32 | 212.54 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | 0.00 | -0.02 | -0.04 |
| Free Cash Flow Per Share | -0.00 | -0.01 | 0.00 | -0.02 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | -38785.67 | 0.00 | 7.44 | -4.51 | -7.73 |
| Capital Expenditure Coverage Ratio | -38785.67 | 0.00 | 7.44 | -4.51 | -7.73 |
| Operating Cash Flow Coverage Ratio | -0.02 | -0.06 | 0.01 | -0.15 | -0.47 |
| Operating Cash Flow to Sales Ratio | -1.27 | -4.20 | 0.19 | -0.77 | -0.99 |
| Free Cash Flow Yield | -28.11% | -69.44% | 15.62% | -10.57% | -14.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.64 | -0.47 | -0.34 | -2.66 | -4.63 |
| Price-to-Sales (P/S) Ratio | 4.53 | 6.05 | 1.22 | 8.26 | 7.78 |
| Price-to-Book (P/B) Ratio | -0.06 | -0.10 | -0.06 | -2.01 | -10.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.56 | -1.44 | 6.40 | -9.46 | -6.95 |
| Price-to-Operating Cash Flow Ratio | -3.56 | -1.44 | 6.40 | -10.69 | -7.85 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.01 | 0.02 | -0.45 | 0.57 |
| Enterprise Value Multiple | -30.24 | -8.42 | -7.03 | -5.69 | -7.93 |
| Enterprise Value | 7.31M | 7.01M | 3.64M | 7.60M | 9.38M |
| EV to EBITDA | -30.24 | -8.42 | -7.03 | -5.69 | -7.93 |
| EV to Sales | 79.99 | 76.91 | 17.85 | 13.02 | 9.79 |
| EV to Free Cash Flow | -62.86 | -18.30 | 93.68 | -14.92 | -8.73 |
| EV to Operating Cash Flow | -62.86 | -18.30 | 93.68 | -16.86 | -9.86 |
| Tangible Book Value Per Share | -0.23 | -0.21 | -0.15 | -0.10 | -0.03 |
| Shareholders’ Equity Per Share | -0.23 | -0.21 | -0.15 | -0.10 | -0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.01 | 0.03 | 0.04 |
| Net Income Per Share | -0.02 | -0.04 | -0.03 | -0.08 | -0.08 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 2.51 | 1.35 | 1.38 | 1.23 | 1.23 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 3.18 | 6.18 | 2.28 | 0.95 | 0.62 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.06 | -0.03 | 0.00 |
| Income Quality | 0.18 | 0.33 | -0.05 | 0.25 | 0.59 |
Currency in CAD
